Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

NovaBridge Biosciences (NBP) Other Gross PP&E Adjustments (2018 - 2025)

NovaBridge Biosciences (NBP) has 8 years of Other Gross PP&E Adjustments data on record, last reported at -$4.1 million in Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 13.7% to -$4.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.1 million, a 13.7% increase, with the full-year FY2025 number at -$4.1 million, up 13.7% from a year prior.
  • Other Gross PP&E Adjustments reached -$4.1 million in Q4 2025 per NBP's latest filing, down from -$2.9 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for NBP hit a ceiling of $8.5 billion in Q4 2022 and a floor of -$10.5 billion in Q4 2021.
  • A 5-year average of $232.9 million and a median of -$3.2 million in 2021 define the central range for Other Gross PP&E Adjustments.
  • Peak YoY movement for Other Gross PP&E Adjustments: tumbled 677472.93% in 2021, then skyrocketed 181.19% in 2022.
  • Tracing NBP's Other Gross PP&E Adjustments over 5 years: stood at -$10.5 billion in 2021, then surged by 181.19% to $8.5 billion in 2022, then plummeted by 40.93% to $5.0 billion in 2023, then crashed by 100.1% to -$4.8 million in 2024, then grew by 13.7% to -$4.1 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for NBP at -$4.1 million in Q4 2025, -$2.9 million in Q3 2025, and -$3.0 million in Q2 2025.